文献速递鼻科

鼻窦炎研究趋势:院外资助的系统综述

Trends in sinusitis research: a systematic review of extramural funding.
PubMed 文献 · Int Forum Allergy Rhinol · 2017-10-06

该研究系统检索NIH RePORTER数据库1993至2017财年鼻窦炎相关项目,共识别958个项目,其中120项仍在活跃。2006至2016年间鼻窦炎相关奖项占比从0.06%升至0.87%,总资助占比从0.09%升至0.90%。ARS成员作为主要研究者仅参与12项(10%)活跃研究,且来自NIAID的资助仅占2.2%,提示最大资助来源未被充分利用。

要点

  • 鼻窦炎研究获NIH资助的项目数及金额占比在2006至2016年间显著增长。
  • ARS成员在活跃鼻窦炎研究中担任主要研究者的比例仅10%。
  • NIAID是鼻窦炎研究最大资助来源,但ARS成员仅获其2.2%的资助。

核心结论

  • 鼻窦炎研究的资助显著增长,但最大活跃资助来源未被ARS成员充分利用。
  • 需进一步促进院外资助来源的优先级以增加对ARS成员研究的资助。

研究设计与样本

  • 系统综述,检索NIH RePORTER数据库1993至2017财年,搜索词为「chronic sinusitis」或「rhinosinusitis」。
  • 所有识别的研究均纳入审查,并与ARS会员名单比对以识别ARS研究者支持的研究。
  • 调查基金会奖项以识别和描述额外资助来源。

主要发现

  • 共识别958个获NIH资助的项目,其中120项仍活跃。
  • 2006至2016年间,鼻窦炎相关奖项占所有NIH奖项的比例从0.06%(8/9128)增至0.87%(86/9540)。
  • 同期鼻窦炎相关总资助占所有NIH资助的比例从0.09%($2,151,152/$3,358,338,602)增至0.90%($37,201,095/$4,300,145,614)。
  • 活跃研究中,9名ARS成员担任主要研究者或项目负责人,参与12项(10%)研究。
  • ARS研究者获NIDCD奖项最多(n=8,66.7%),而来自NIAID的资助仅占2.2%($607,500/$26,873,022),后者是鼻窦炎研究最大奖项来源。

临床怎么用

  • 提示ARS成员可关注NIAID等资助来源,以增加鼻窦炎研究资助获取。
  • 为促进ARS成员研究资助,需进一步推动院外资助来源的优先级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Innovation represents a core value of the American Rhinologic Society (ARS), with multiple efforts to promote research in the advancement rhinologic care. We therefore sought to identify trends in extramural sinusitis funding and underutilized sources of support to facilitate future efforts. METHODS: A systematic review of the National Institutes of Health (NIH) Research Portfolio Online Tools (RePORTER) database (fiscal year 1993 to 2017) was completed with the search strategy: ("chronic sinusitis" OR rhinosinusitis). All identified studies were accepted for review, with comparison to ARS membership rolls to identify studies supported by ARS investigators. Foundation awards were surveyed to identify and characterize additional sources of support. RESULTS: The systematic review identified 958 projects receiving NIH funding, of which 120 remain active. The percentage of sinusitis-related awards and total funding relative to all NIH awards increased over the past 10 years (2006 to 2016) from 0.06% (8 / 9128) and 0.09% ($2,151,152 / $3,358,338,602) to 0.87% (86 / 9540) and 0.90% ($37,201,095 / $4,300,145,614). Among active studies, 9 investigators maintain membership in the ARS and serve as principal investigator or project leader in 12 (10%) studies. ARS investigators received the greatest number of awards from the National Institute on Deafness and Other Communication Disrders (n = 8,66.7%), while only receiving 2.2% of awarded funding from the National Institute of Allergy and Infectious Diseases ($607,500/$26,873,022), the largest source of awards for sinusitis research. CONCLUSION: Support for sinusitis research is significantly growing, with the largest source of active funding not being fully utilized by members of the ARS. Further efforts to promote funding priorities among extramural sources is necessary to facilitate increased funding for ARS member initiatives.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Levy JM, Smith SS, Varshney R, et al. Trends in sinusitis research: a systematic review of extramural funding. Int Forum Allergy Rhinol. 2017. PMID: 28985031. doi:10.1002/alr.22015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。